Cat FHV Respiratory Disease Management

Feline herpesvirus-1 causes persistent respiratory disease in cats that requires long-term management to reduce recurrence and maintain welfare.

Key Facts

FHV-1 infects the respiratory epithelium and establishes lifelong latent infection in trigeminal ganglia
Sneezing, nasal discharge, conjunctivitis, and corneal ulceration characterize acute FHV-1 outbreaks
Stress is the primary trigger for viral reactivation causing recurrent upper respiratory disease
L-lysine supplementation was widely used but evidence supporting its efficacy is now considered insufficient
Antiviral therapy with famciclovir significantly reduces severity and duration of acute FHV-1 episodes

Welfare Considerations

Cats with recurrent FHV-1 upper respiratory disease experience cyclical discomfort from nasal congestion, conjunctival irritation, and corneal pain that reduces their daily welfare during flare periods. The stress-triggered nature of reactivation creates a feedback loop where the welfare stress of illness itself can trigger further reactivation. Management focuses on reducing environmental stressors that trigger reactivation, ensuring adequate nutrition to support immune function, and providing antiviral treatment during acute episodes to shorten their duration and severity. Shelter cats with chronic upper respiratory disease from FHV-1 infection face reduced adoption prospects, creating additional welfare challenges from prolonged institutional care.

What You Can Do

Minimize household stressors and maintain consistent routines for cats with known FHV-1 infection
Discuss antiviral medication with your vet for cats with frequent severe FHV-1 outbreaks
Ensure infected cats receive excellent nutrition to support immune management of latent infection
Provide appropriate environmental enrichment that reduces boredom-related stress without overwhelming sensitive cats